Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)

SHA:688192 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,524	17,237	19,530	16,030	14,959	-
Market Cap Growth	43.75%	-11.74%	21.83%	7.16%	-	-
Enterprise Value	27,664	17,342	18,891	14,518	14,805	-
Last Close Price	61.85	41.47	47.85	39.37	37.01	-
PS Ratio	46.93	47.89	213.94	-	1454.37	-
PB Ratio	19.76	86.16	23.01	9.12	6.07	-
P/TBV Ratio	27.54	-	50.51	12.66	7.53	-
EV/Sales Ratio	45.52	48.18	206.94	-	1439.37	-
Debt / Equity Ratio	0.74	5.79	0.48	0.05	0.04	-
Asset Turnover	0.26	0.22	0.05	-	0.01	0.03
Inventory Turnover	0.81	0.35	0.54	-	-	-
Quick Ratio	2.38	1.11	1.78	5.70	9.82	5.88
Current Ratio	2.47	1.27	2.03	5.93	9.96	6.06
Return on Equity (ROE)	-92.82%	-179.21%	-84.98%	-34.87%	-37.83%	-76.72%
Return on Assets (ROA)	-24.53%	-37.70%	-40.35%	-20.52%	-21.46%	-52.76%
Return on Capital (ROIC)	-29.32%	-46.33%	-46.54%	-22.54%	-23.23%	-62.42%
Return on Capital Employed (ROCE)	-43.10%	-103.90%	-110.20%	-43.20%	-26.60%	-70.80%
Earnings Yield	-3.04%	-4.91%	-5.67%	-4.59%	-4.48%	-
FCF Yield	-2.82%	-4.57%	-5.12%	-4.22%	-3.35%	-
Buyback Yield / Dilution	-5.52%	-1.83%	-0.70%	-12.29%	-0.07%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.